37,842 Shares in Tempus AI, Inc. (NASDAQ:TEM) Bought by RFG Advisory LLC

RFG Advisory LLC bought a new stake in Tempus AI, Inc. (NASDAQ:TEM - Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 37,842 shares of the company's stock, valued at approximately $1,826,000.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. ARK Investment Management LLC raised its stake in shares of Tempus AI by 132.1% during the 4th quarter. ARK Investment Management LLC now owns 5,519,644 shares of the company's stock worth $186,343,000 after buying an additional 3,141,487 shares during the last quarter. Nikko Asset Management Americas Inc. raised its stake in shares of Tempus AI by 166.0% during the 4th quarter. Nikko Asset Management Americas Inc. now owns 3,239,093 shares of the company's stock worth $109,352,000 after buying an additional 2,021,394 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. raised its stake in shares of Tempus AI by 166.0% during the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,239,093 shares of the company's stock worth $109,352,000 after buying an additional 2,021,394 shares during the last quarter. Franklin Resources Inc. raised its stake in shares of Tempus AI by 240.5% during the 4th quarter. Franklin Resources Inc. now owns 2,762,173 shares of the company's stock worth $93,251,000 after buying an additional 1,950,862 shares during the last quarter. Finally, JPMorgan Chase & Co. raised its stake in shares of Tempus AI by 86,947.2% during the 4th quarter. JPMorgan Chase & Co. now owns 1,653,896 shares of the company's stock worth $55,836,000 after buying an additional 1,651,996 shares during the last quarter. Institutional investors and hedge funds own 24.22% of the company's stock.

Analyst Ratings Changes

Several research analysts have recently issued reports on the company. Morgan Stanley lifted their price target on Tempus AI from $60.00 to $65.00 and gave the stock an "overweight" rating in a research note on Friday, May 9th. BTIG Research assumed coverage on Tempus AI in a research note on Monday, April 21st. They set a "buy" rating and a $60.00 price target for the company. Wolfe Research downgraded Tempus AI from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, February 26th. Needham & Company LLC reiterated a "buy" rating and set a $70.00 price objective on shares of Tempus AI in a research report on Wednesday, May 7th. Finally, Bank of America lifted their price objective on Tempus AI from $48.00 to $68.00 and gave the stock a "neutral" rating in a research report on Tuesday, May 20th. Six equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat, Tempus AI has an average rating of "Moderate Buy" and an average price target of $63.42.

Tempus AI Trading Down 6.6%

TEM traded down $4.12 during midday trading on Thursday, hitting $58.66. The company's stock had a trading volume of 12,213,960 shares, compared to its average volume of 6,836,817. The firm has a 50-day moving average price of $52.98 and a two-hundred day moving average price of $52.01. The firm has a market cap of $10.15 billion and a P/E ratio of -7.52. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17. Tempus AI, Inc. has a 52-week low of $22.89 and a 52-week high of $91.45.

Tempus AI (NASDAQ:TEM - Get Free Report) last released its quarterly earnings results on Tuesday, May 6th. The company reported ($0.24) EPS for the quarter, topping the consensus estimate of ($0.27) by $0.03. The company had revenue of $255.74 million for the quarter, compared to analyst estimates of $248.13 million. Tempus AI's revenue was up 75.4% on a year-over-year basis. On average, research analysts anticipate that Tempus AI, Inc. will post -6.15 earnings per share for the current year.

Insider Buying and Selling at Tempus AI

In related news, Director Wayne A.I. Frederick sold 3,000 shares of the company's stock in a transaction that occurred on Monday, March 31st. The stock was sold at an average price of $45.54, for a total transaction of $136,620.00. Following the sale, the director now directly owns 26,514 shares of the company's stock, valued at approximately $1,207,447.56. This represents a 10.16% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CAO Ryan M. Bartolucci sold 6,073 shares of the company's stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $63.23, for a total value of $383,995.79. Following the sale, the chief accounting officer now directly owns 47,799 shares in the company, valued at approximately $3,022,330.77. This represents a 11.27% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 139,888 shares of company stock valued at $7,938,111 in the last three months. Corporate insiders own 27.60% of the company's stock.

Tempus AI Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.